01/09/2025 | Press release | Distributed by Public on 01/09/2025 04:20
Research Highlights:
Embargoed until 4 a.m. CT/5 a.m. ET Thursday, January 9, 2025
DALLAS, Jan. 9, 2025 - Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond, according to new research published today in Hypertension, a peer-reviewed journal of the American Heart Association.
People who recently gave birth can be at an elevated risk of developing high blood pressure, or postpartum hypertension. Although rare, this can sometimes be life-threatening and may be associated with developing heart disease later in life, and the risk is elevated in people that had any pregnancy-related high blood pressure issue such as preeclampsia.
In the current study, the authors examined the potential association between high blood pressure and gender-based racial microaggressions - subtle unintentional slights, such as being told to calm down - experienced while receiving health care services during pregnancy and delivery.
"It is well-known that Black, Hispanic and South Asian women experience microaggressions during health care. It is not as well known whether these microaggressions may have an association with higher blood pressure," said lead study author Teresa Janevic, Ph.D., M.P.H., an associate professor of epidemiology at Columbia University Mailman School of Public Health in New York.
Researchers used the Gendered Racial Microaggressions Scale (GRMS), adapted into a 26-item, four-factor scale, to ask 373 Asian, Black and Hispanic study participants delivering at four hospitals in Philadelphia and New York City how frequently they experienced gendered racial microaggressions. The participants were asked to check their blood pressure at home for three months after birth using text-based monitoring. They also estimated community-level structural racism with the Structural Racism Effect Index, a publicly available national index.
The analysis found:
"It's surprising the associations were strongest in the later postpartum period between 12 days and three months after delivery. This is an emerging critical period for preventing high blood pressure," Janevic said. "Our findings provide further evidence that health care professionals and policies should focus more intensely on improving maternal health care equity. We need high blood pressure monitoring and interventions to extend further into the period after birth when blood pressure may continue to be sensitive to social drivers of health as well as racial microaggressions."
Future research is needed to explore how experiencing racism influences blood pressure, to understand the potential health effects on infants and to identify the best interventions to improve postpartum health, Janevic noted.
"This work serves as a reminder of the long-term impact that racism can have on one's overall health. The magnitude of these types of physiologic changes may become cumulative over time and lead to the inequities we see in many health outcomes," said senior study author Lisa Levine, M.D., M.S.C.E., the Michael T. Mennuti, M.D., Associate Professor in Reproductive Health, director of the Pregnancy and Heart Disease Program and chief of the Maternal Fetal Medicine Division at the University of Pennsylvania Perelman School of Medicine.
The study had limitations, including that researchers did not know the participants' blood pressure trends before pregnancy, meaning they did not know how much of the data collected reflects those pre-pregnancy trends. Additionally, the researchers did not collect other health information that could influence blood pressure, such as diet; and, because this study was conducted in only two large cities, the findings may not be generalizable to more rural settings. The authors also noted that future research is needed to link postpartum blood pressure trends to midlife heart health.
"The synergistic effects of experiencing gendered racial microaggressions and high levels of place-based structural racism were profound, resulting in a nearly 8mmHg higher systolic blood pressure. For many people, this can make the difference between needing blood pressure lowering medications or not," said Natalie A. Cameron, M.D, M.P.H., an internal medicine specialist and instructor in preventive medicine at Northwestern University's Feinberg School of Medicine, who was not involved in the study. Cameron is also a member of the Association's Council on Epidemiology and Prevention and Council on Lifestyle and Cardiometabolic Health.
"These results emphasize that hypertension management needs to extend beyond prescription medications," she said. "Future work is needed to design interventions that reduce gendered racial microaggressions in the health care setting and investigate their effects on postpartum blood pressure."
Study design, background and details:
Co-authors, disclosures and funding sources are listed in the manuscript.
Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association's overall financial information are available here.
Additional Resources:
###
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.
For Media Inquiries: 214-706-1173
John Arnst: [email protected]
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org